MedPath

LESS Surgery Versus Conventional Multiport Laparoscopy in Ovarian Drilling

Not Applicable
Completed
Conditions
Operative Time
Successful Surgical Procedure
Intra- and Post- Operative Complications
Cosmetic Outcome
Interventions
Device: laparoscopic ovarian drilling
Registration Number
NCT03206892
Lead Sponsor
Ain Shams Maternity Hospital
Brief Summary

laparoendoscopic single-site surgery is compared to conventional multi-port laparoscopy for polycystic ovary syndrome in infertile women undergoing ovarian drilling as regards successful surgical procedure with less side effects

Detailed Description

Laparoendoscopic single-site surgery; one of the most recent advances in the field of minimally invasive surgery, is the use of a single incision in the umbilicus for laparoscopic surgeries, is compared to the conventional multi-port laparoscopy for polycystic ovary syndrome in infertile women undergoing ovarian drilling as regards successful surgical procedure without conversion to laparotomy or use of an additional port in the single site group. in addition to operative time, intra- and post- operative complications and cosmetic outcome.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
70
Inclusion Criteria
  • PCOS according to Rotterdam Criteria (2 out of 3):
  • polycystic ovaries (12 or more follicles in each ovary and/or increased ovarian volume >10 cm3).
  • oligo- or an-ovulation.
  • clinical and/or biochemical hyperandrogenisim. After exclusion of other aetiologies for irregular cycles.
  • Indications of laparoscopic ovarian drilling:
  • clomiphene citrate- resistance or failure: failure to conceive after 6 to 9 cycles.
  • other indications for laparoscopy.
  • before gonadotropin administration to decrease risk of OHSS and multiple pregnancy.
  • before ART to decrease risk of severe OHSS in women who previously had canceled IVF cycles due to OHSS risk or who suffered from OHSS in a previous treatment.
Exclusion Criteria
  • previous 2 or more laparotomies.
  • chronic pelvic pain, endometriosis or pelvic inflammatory diseases to avoid pelvic adhesions and bias in the quantification of postoperative pain.
  • High BMI (>35kg/m2)
  • do not possess a native umbilicus.
  • advanced gynaecological surgeries or malignant disorders (TLH, ALVH, laparoscopic myomectomy).
  • contraindication to any laparoscopy like any medical condition worsened by pneumoperitoneum or Trendelnburg position.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LESS surgerylaparoscopic ovarian drillingLaparoscopic ovarian drilling for polycystic ovary syndrome in infertile women using laparoendoscopic single-site surgery (single incision through the umbilicus using modified Hasson technique).
conventional multi-port laparoscopylaparoscopic ovarian drillinglaparoscopic ovarian drilling for polycystic ovary syndrome in infertile women using conventional multi-port laparoscopy (three port system using a closed technique on the umbilicus, left and right lower quadrant areas).
Primary Outcome Measures
NameTimeMethod
successful surgical procedure1 hour (minutes)

without conversion to laparotomy or the use of an additional port in the single-site group (number of ports).

Secondary Outcome Measures
NameTimeMethod
intraoperative complications1 hour

blood transfusion (number of units), bowel, bladder or ureteric injuries

intraoperative blood loss24 hour after end of procedure

amount of blood in the suction bottle (mL), drop in postoperative haemoglobin (g/dl)

operative time1 hour (minutes)

from trocar insertion to last skin stitch (minutes)

postoperative hospital stay3 days

number of days

postoperative complications1st week

hematoma, wound infection, ileus, UTI

postoperative pain1st day

visual analogue scale (0-10 scale), number of postoperative analgesic ampules needed

cosmetic outcomeday 1 and day 7

scar image

Trial Locations

Locations (1)

Ain Shams University Maternity Hospital

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath